Risk factors of contrast-induced nephropathy in patients with acute coronary syndrome.


Journal

Kardiologia polska
ISSN: 1897-4279
Titre abrégé: Kardiol Pol
Pays: Poland
ID NLM: 0376352

Informations de publication

Date de publication:
2022
Historique:
received: 06 05 2022
accepted: 06 05 2022
pubmed: 7 5 2022
medline: 9 9 2022
entrez: 6 5 2022
Statut: ppublish

Résumé

Patients with acute coronary syndrome (ACS) are at high risk of contrast-induced nephropathy (CIN), which is associated with prolonged hospitalization, higher morbidity and mortality after angiographic procedures. The occurrence of CIN is regarded as a transient and reversible condition. However, the persistence of CIN until hospital discharge in patients with ACS has not been thoroughly analyzed. We aimed to analyze CIN persistent until hospital discharge in contemporary ACS population referred to invasive diagnostics and treatment. A total of 2638 consecutive patients with ACS were included in a prospective registry. The occurrence of CIN was defined as a 25% increase in serum creatinine from baseline or a 0.5 mg/dl (44 μmol/l) increase in the absolute value. Criteria of CIN at hospital discharge were met in 10.7% of patients. Immediate percutaneous coronary intervention (PCI) after angiography (67% of patients) was associated with higher rates of CIN compared to patients referred for other treatment strategies (P < 0.001). The logistic regression model showed that anemia at baseline (8.7% of patients) was an independent predictor of CIN, which occurred in 17.9% of anemic patients and 10% of patients without anemia (P < 0.001). Also, ST-segment elevation myocardial infarction (STEMI) presentation and immediate PCI were independent predictors of CIN. Despite intravenous fluid administration during the hospital stay, CIN persisted until hospital discharge in more than 10% of patients with ACS. Anemia at baseline, STEMI presentation, and immediate PCI strategy were independent predictors of CIN. Thus, preventive actions should be specially aimed at those groups of patients.

Sections du résumé

BACKGROUND
Patients with acute coronary syndrome (ACS) are at high risk of contrast-induced nephropathy (CIN), which is associated with prolonged hospitalization, higher morbidity and mortality after angiographic procedures. The occurrence of CIN is regarded as a transient and reversible condition. However, the persistence of CIN until hospital discharge in patients with ACS has not been thoroughly analyzed.
AIMS
We aimed to analyze CIN persistent until hospital discharge in contemporary ACS population referred to invasive diagnostics and treatment.
METHODS
A total of 2638 consecutive patients with ACS were included in a prospective registry. The occurrence of CIN was defined as a 25% increase in serum creatinine from baseline or a 0.5 mg/dl (44 μmol/l) increase in the absolute value.
RESULTS
Criteria of CIN at hospital discharge were met in 10.7% of patients. Immediate percutaneous coronary intervention (PCI) after angiography (67% of patients) was associated with higher rates of CIN compared to patients referred for other treatment strategies (P < 0.001). The logistic regression model showed that anemia at baseline (8.7% of patients) was an independent predictor of CIN, which occurred in 17.9% of anemic patients and 10% of patients without anemia (P < 0.001). Also, ST-segment elevation myocardial infarction (STEMI) presentation and immediate PCI were independent predictors of CIN.
CONCLUSIONS
Despite intravenous fluid administration during the hospital stay, CIN persisted until hospital discharge in more than 10% of patients with ACS. Anemia at baseline, STEMI presentation, and immediate PCI strategy were independent predictors of CIN. Thus, preventive actions should be specially aimed at those groups of patients.

Identifiants

pubmed: 35521717
pii: VM/OJS/J/89953
doi: 10.33963/KP.a2022.0123
doi:

Substances chimiques

Contrast Media 0
Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

760-764

Auteurs

Tomasz Rakowski (T)

Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland. mcrakows@cyfronet.pl.

Artur Dziewierz (A)

Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.

Michał Węgiel (M)

Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.

Zbigniew Siudak (Z)

Collegium Medicum, Jan Kochanowski University, Kielce, Poland.

Wojciech Zasada (W)

2nd Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland.

Jacek Jąkała (J)

Krakow Center of Invasive Cardiology, Electrotherapy and Angiology, Kraków, Poland.

Dominika Dykla (D)

Center of Invasive Cardiology, Electrotherapy and Angiology in Nowy Sącz, Nowy Sącz, Poland.

Jerzy Matysek (J)

Krakow Center of Invasive Cardiology, Electrotherapy and Angiology, Kraków, Poland.

Andrzej Surdacki (A)

Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.

Stanisław Bartuś (S)

Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.

Dariusz Dudek (D)

Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.

Roman Wojdyła (R)

2nd Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH